Breaking news from The Wall Street Journal.
News Alert | J&J Single-Dose Covid-19 Vaccine Gains Backing From FDA Advisory Panel |
|
| Johnson & Johnson’s single-dose Covid-19 vaccine worked safely and should be authorized for use in the U.S., a panel of experts advised federal health regulators. The advisory committee’s vote in support of the vaccine’s authorization is the last step before the U.S. Food and Drug Administration issues a decision, which is expected within days. |
| | Read WSJ's latest headlines › | |
|
|